Report Detail
Global Oral Vaccine for Human Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4742383 |
- 28 September, 2026 |
- Global |
- 111 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Oral Vaccine for Human market size was valued at US$ 3059 million in 2025 and is forecast to a readjusted size of US$ 4442 million by 2032 with a CAGR of 5.5% during review period.
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.
The oral vaccine market is driven by the growing demand for convenient and needle-free vaccination options, especially in pediatric and developing regions. Oral vaccines offer advantages like ease of administration, increased patient compliance, and simplified logistics, making them suitable for mass vaccination programs and reaching remote areas with limited healthcare infrastructure. The potential for improved vaccine stability and reduced production costs further contribute to market growth. However, the market also faces challenges, such as the need for enhanced vaccine stability to withstand gastrointestinal conditions and ensuring consistent efficacy across diverse populations. Additionally, regulatory complexities and the requirement for stringent safety and efficacy data can pose obstacles for oral vaccine manufacturers. To succeed in this market, companies must focus on innovative vaccine delivery technologies, conduct robust clinical trials, collaborate with global health agencies, and address public perception and trust in oral vaccine safety and effectiveness.
This report is a detailed and comprehensive analysis for global Oral Vaccine for Human market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Vaccine for Human market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Vaccine for Human market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Vaccine for Human market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Vaccine for Human market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Vaccine for Human
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Vaccine for Human market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Vaccine for Human market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Market segment by Application
Public
Private
Major players covered
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Vaccine for Human product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Vaccine for Human, with price, sales quantity, revenue, and global market share of Oral Vaccine for Human from 2021 to 2026.
Chapter 3, the Oral Vaccine for Human competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Vaccine for Human breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Vaccine for Human market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Vaccine for Human.
Chapter 14 and 15, to describe Oral Vaccine for Human sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oral Vaccine for Human Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Rotavirus Vaccine
- 1.3.3 Cholera Vaccine
- 1.3.4 Oral Polio Vaccine
- 1.3.5 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Oral Vaccine for Human Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Public
- 1.4.3 Private
- 1.5 Global Oral Vaccine for Human Market Size & Forecast
- 1.5.1 Global Oral Vaccine for Human Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Oral Vaccine for Human Sales Quantity (2021-2032)
- 1.5.3 Global Oral Vaccine for Human Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Merck
- 2.1.1 Merck Details
- 2.1.2 Merck Major Business
- 2.1.3 Merck Oral Vaccine for Human Product and Services
- 2.1.4 Merck Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Merck Recent Developments/Updates
- 2.2 GSK
- 2.2.1 GSK Details
- 2.2.2 GSK Major Business
- 2.2.3 GSK Oral Vaccine for Human Product and Services
- 2.2.4 GSK Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 GSK Recent Developments/Updates
- 2.3 Sanofi
- 2.3.1 Sanofi Details
- 2.3.2 Sanofi Major Business
- 2.3.3 Sanofi Oral Vaccine for Human Product and Services
- 2.3.4 Sanofi Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Sanofi Recent Developments/Updates
- 2.4 Lanzhou Institute
- 2.4.1 Lanzhou Institute Details
- 2.4.2 Lanzhou Institute Major Business
- 2.4.3 Lanzhou Institute Oral Vaccine for Human Product and Services
- 2.4.4 Lanzhou Institute Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Lanzhou Institute Recent Developments/Updates
- 2.5 Serum Institute
- 2.5.1 Serum Institute Details
- 2.5.2 Serum Institute Major Business
- 2.5.3 Serum Institute Oral Vaccine for Human Product and Services
- 2.5.4 Serum Institute Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Serum Institute Recent Developments/Updates
- 2.6 Valneva
- 2.6.1 Valneva Details
- 2.6.2 Valneva Major Business
- 2.6.3 Valneva Oral Vaccine for Human Product and Services
- 2.6.4 Valneva Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Valneva Recent Developments/Updates
- 2.7 Shanghai United Cell
- 2.7.1 Shanghai United Cell Details
- 2.7.2 Shanghai United Cell Major Business
- 2.7.3 Shanghai United Cell Oral Vaccine for Human Product and Services
- 2.7.4 Shanghai United Cell Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Shanghai United Cell Recent Developments/Updates
- 2.8 Bibcol
- 2.8.1 Bibcol Details
- 2.8.2 Bibcol Major Business
- 2.8.3 Bibcol Oral Vaccine for Human Product and Services
- 2.8.4 Bibcol Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Bibcol Recent Developments/Updates
- 2.9 PaxVax
- 2.9.1 PaxVax Details
- 2.9.2 PaxVax Major Business
- 2.9.3 PaxVax Oral Vaccine for Human Product and Services
- 2.9.4 PaxVax Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 PaxVax Recent Developments/Updates
- 2.10 Vabiotech
- 2.10.1 Vabiotech Details
- 2.10.2 Vabiotech Major Business
- 2.10.3 Vabiotech Oral Vaccine for Human Product and Services
- 2.10.4 Vabiotech Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Vabiotech Recent Developments/Updates
- 2.11 Tiantan Biological
- 2.11.1 Tiantan Biological Details
- 2.11.2 Tiantan Biological Major Business
- 2.11.3 Tiantan Biological Oral Vaccine for Human Product and Services
- 2.11.4 Tiantan Biological Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Tiantan Biological Recent Developments/Updates
- 2.12 EuBiologics
- 2.12.1 EuBiologics Details
- 2.12.2 EuBiologics Major Business
- 2.12.3 EuBiologics Oral Vaccine for Human Product and Services
- 2.12.4 EuBiologics Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 EuBiologics Recent Developments/Updates
- 2.13 Panacea Biotec Ltd
- 2.13.1 Panacea Biotec Ltd Details
- 2.13.2 Panacea Biotec Ltd Major Business
- 2.13.3 Panacea Biotec Ltd Oral Vaccine for Human Product and Services
- 2.13.4 Panacea Biotec Ltd Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Panacea Biotec Ltd Recent Developments/Updates
- 2.14 Bio-Med
- 2.14.1 Bio-Med Details
- 2.14.2 Bio-Med Major Business
- 2.14.3 Bio-Med Oral Vaccine for Human Product and Services
- 2.14.4 Bio-Med Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Bio-Med Recent Developments/Updates
- 2.15 Halfkin Bio-Pharmaceuticals
- 2.15.1 Halfkin Bio-Pharmaceuticals Details
- 2.15.2 Halfkin Bio-Pharmaceuticals Major Business
- 2.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Product and Services
- 2.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccine for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Oral Vaccine for Human by Manufacturer
- 3.1 Global Oral Vaccine for Human Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Oral Vaccine for Human Revenue by Manufacturer (2021-2026)
- 3.3 Global Oral Vaccine for Human Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Oral Vaccine for Human by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Oral Vaccine for Human Manufacturer Market Share in 2025
- 3.4.3 Top 6 Oral Vaccine for Human Manufacturer Market Share in 2025
- 3.5 Oral Vaccine for Human Market: Overall Company Footprint Analysis
- 3.5.1 Oral Vaccine for Human Market: Region Footprint
- 3.5.2 Oral Vaccine for Human Market: Company Product Type Footprint
- 3.5.3 Oral Vaccine for Human Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Oral Vaccine for Human Market Size by Region
- 4.1.1 Global Oral Vaccine for Human Sales Quantity by Region (2021-2032)
- 4.1.2 Global Oral Vaccine for Human Consumption Value by Region (2021-2032)
- 4.1.3 Global Oral Vaccine for Human Average Price by Region (2021-2032)
- 4.2 North America Oral Vaccine for Human Consumption Value (2021-2032)
- 4.3 Europe Oral Vaccine for Human Consumption Value (2021-2032)
- 4.4 Asia-Pacific Oral Vaccine for Human Consumption Value (2021-2032)
- 4.5 South America Oral Vaccine for Human Consumption Value (2021-2032)
- 4.6 Middle East & Africa Oral Vaccine for Human Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Oral Vaccine for Human Sales Quantity by Type (2021-2032)
- 5.2 Global Oral Vaccine for Human Consumption Value by Type (2021-2032)
- 5.3 Global Oral Vaccine for Human Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Oral Vaccine for Human Sales Quantity by Application (2021-2032)
- 6.2 Global Oral Vaccine for Human Consumption Value by Application (2021-2032)
- 6.3 Global Oral Vaccine for Human Average Price by Application (2021-2032)
7 North America
- 7.1 North America Oral Vaccine for Human Sales Quantity by Type (2021-2032)
- 7.2 North America Oral Vaccine for Human Sales Quantity by Application (2021-2032)
- 7.3 North America Oral Vaccine for Human Market Size by Country
- 7.3.1 North America Oral Vaccine for Human Sales Quantity by Country (2021-2032)
- 7.3.2 North America Oral Vaccine for Human Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Oral Vaccine for Human Sales Quantity by Type (2021-2032)
- 8.2 Europe Oral Vaccine for Human Sales Quantity by Application (2021-2032)
- 8.3 Europe Oral Vaccine for Human Market Size by Country
- 8.3.1 Europe Oral Vaccine for Human Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Oral Vaccine for Human Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Oral Vaccine for Human Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Oral Vaccine for Human Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Oral Vaccine for Human Market Size by Region
- 9.3.1 Asia-Pacific Oral Vaccine for Human Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Oral Vaccine for Human Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Oral Vaccine for Human Sales Quantity by Type (2021-2032)
- 10.2 South America Oral Vaccine for Human Sales Quantity by Application (2021-2032)
- 10.3 South America Oral Vaccine for Human Market Size by Country
- 10.3.1 South America Oral Vaccine for Human Sales Quantity by Country (2021-2032)
- 10.3.2 South America Oral Vaccine for Human Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Oral Vaccine for Human Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Oral Vaccine for Human Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Oral Vaccine for Human Market Size by Country
- 11.3.1 Middle East & Africa Oral Vaccine for Human Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Oral Vaccine for Human Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Oral Vaccine for Human Market Drivers
- 12.2 Oral Vaccine for Human Market Restraints
- 12.3 Oral Vaccine for Human Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Oral Vaccine for Human and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Oral Vaccine for Human
- 13.3 Oral Vaccine for Human Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Oral Vaccine for Human Typical Distributors
- 14.3 Oral Vaccine for Human Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Oral Vaccine for Human. Industry analysis & Market Report on Oral Vaccine for Human is a syndicated market report, published as Global Oral Vaccine for Human Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Oral Vaccine for Human market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
